# SEROQUEL XR

NDC: 61269-271
Generic name: quetiapine
Labeler / Manufacturer: H2-Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20090201

FDA application: NDA022047

## Active ingredients

- QUETIAPINE FUMARATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61269-271"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61269-271
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab959a35-d0ba-4f18-8f2e-6619d88b16e3